Denmark-based, Tetra Pharm Technologies (TPT) is a biotech startup committed to treat neuropathic pain & mental health disorders, by “designing & developing new drug formulations/ candidates, conducting clinicals & commercializing medicines targeting the endocannabinoid system (ECS)”. <Quick primer on the ECS: it regulates & controls many critical body functions such as, via CB1 receptors (found mostly in the brain) - learning & memory, emotional processing, sleep, temperature control, pain control, & via CB2 receptors (found mostly in tissue) - inflammatory & immune responses >. Worth keeping mind, the European market for cannabinoid-based treatment is expected to reach €3.2b by 2025. TPT is said to have closed “several significant distribution deals” across main European markets &...

France-based, Hyperplan develops a crop monitoring platform, which uses satellite imaging to recognize plant maturity (2-4 months before harvest, depending on the crop), project ensuing volume (with the addition of meteorological data) & control start/ duration of the harvesting progress incl. e.g. identifying capacity risks in the supply chain (collection points, silos or processing facilities). The software also optimizes allocation of resources for operational (e.g. maintenance CAPEX) & strategic investments (e.g. supply chain overhaul, “sector farming”). The expected benefit of using Hyperlan is €2-4 per ton of raw agricultural product collected, through (among other) the reduction of product losses/ quality degradation by 10-15%. Hyperplan already monitors 25m hectares of agricultural production in France, for clients...